Oct 26, 2016
3:1
For every share held, investors received 3. The price per share adjusted from $19.50 to $6.50.
The split itself did not change the total investment value.
Tianjin Chase Sun Pharmaceutical Co., Ltd. Class A (SZSE:300026) operates in the Pharmaceuticals: major industry.
Tianjin Chase Sun Pharmaceutical Co., Ltd. Class A company overviewTianjin Chase Sun Pharmaceutical Co., Ltd. Class A's most recent stock split was on October 26, 2016. It was a 3-for-1 forward split, so shareholders received 3 shares for every share they held.
Tianjin Chase Sun Pharmaceutical Co., Ltd. Class A (SZSE:300026) has split its stock 7 times: a 2-for-1 split on May 10, 2010, a 3-for-2 split on May 19, 2011, a 3-for-2 split on May 10, 2012, a 3-for-2 split on May 7, 2013, a 3-for-2 split on May 19, 2014, a 3-for-2 split on June 12, 2015, and a 3-for-1 split on October 26, 2016.
Tianjin Chase Sun Pharmaceutical Co., Ltd. Class A has split its stock 7 times. This history records 7 forward splits between May 10, 2010 and October 26, 2016.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Tianjin Chase Sun Pharmaceutical Co., Ltd. Class A's 3-for-1 split on October 26, 2016, every share became 3 shares.
Tianjin Chase Sun Pharmaceutical Co., Ltd. Class A has not announced a new split in our records. Its most recent split was on October 26, 2016, 10 years ago. Companies announce splits in advance, and any new SZSE:300026 split will appear on this page.
Already premium?